In this context, exclusively exocrine pancreatic adenocarcinomas of ductal origin (PDA) and endocrine origin (PENs) have been included, de novo CDKN2A promoter hypermethylation was detected and shown to contribute to the tumorigenesis in both types. This evidence concerns the gene CDKN2A and Patent ductus arteriosus.